OrthoXel DAC is an emerging medical device startup company founded in 2014 to develop and commercialise orthopaedic trauma products.
The first technology that OrthoXel will commercialise is a novel intramedullary nail for treatment of tibia and femoral fractures (Apex Nailing system ). The basic R&D and proof of principle was completed in Cork Institute of Technology’s MEDIC centre over a 5 year timeframe.
That development program included iterative design-build-test activities such as bench testing, cadaver studies, and a GLP-controlled preclinical study. The output from the development program is patent-protected for tibial, femoral, and humeral use.
OrthoXel will bring the Apex Tibial Nailing system through regulatory approval and clinical studies in early 2017, followed by the Apex Femoral Nailing system.